肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2020年版中成药治疗慢性肾脏病3-5期(非透析)临床应用指南解读

2021-09-10 陕西省中医医院 现代中医药

慢性肾脏病

2020年《中成药治疗优势病种临床应用指南》标准化项目组正式发布了《中成药治疗慢性肾脏病3-5期(非透析)临床应用指南》。该指南基于解决临床关键问题,涵盖了临床常用的治疗慢性肾脏病的中成药的临床指标改

中文标题：

2020年版中成药治疗慢性肾脏病3-5期(非透析)临床应用指南解读

发布机构：

陕西省中医医院

发布日期：

2021-09-10

简要介绍：

2020年《中成药治疗优势病种临床应用指南》标准化项目组正式发布了《中成药治疗慢性肾脏病3-5期(非透析)临床应用指南》。该指南基于解决临床关键问题,涵盖了临床常用的治疗慢性肾脏病的中成药的临床指标改善情况、使用条件、安全性及证据描述,共计8条推荐意见。结合指南,主要介绍该指南的制订背景和方法学,并对临床常用的治疗慢性肾脏病3-5期(非透析)的主要中成药的相关内容进行解读。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020年版中成药治疗慢性肾脏病3-5期(非透析)临床应用指南解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=37bca1c002352946, title=2020年版中成药治疗慢性肾脏病3-5期(非透析)临床应用指南解读, enTitle=, guiderFrom=现代中医药, authorId=0, author=, summary=2020年《中成药治疗优势病种临床应用指南》标准化项目组正式发布了《中成药治疗慢性肾脏病3-5期(非透析)临床应用指南》。该指南基于解决临床关键问题,涵盖了临床常用的治疗慢性肾脏病的中成药的临床指标改, cover=https://img.medsci.cn/2022212/1644596213375_5579292.jpg, journalId=0, articlesId=null, associationId=2406, associationName=陕西省中医医院, associationIntro=陕西省中医医院, copyright=0, guiderPublishedTime=Fri Sep 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2020年《中成药治疗优势病种临床应用指南》标准化项目组正式发布了《中成药治疗慢性肾脏病3-5期(非透析)临床应用指南》。该指南基于解决临床关键问题,涵盖了临床常用的治疗慢性肾脏病的中成药的临床指标改善情况、使用条件、安全性及证据描述,共计8条推荐意见。结合指南,主要介绍该指南的制订背景和方法学,并对临床常用的治疗慢性肾脏病3-5期(非透析)的主要中成药的相关内容进行解读。&nbsp;</span></p>, tagList=[TagDto(tagId=2527, tagName=慢性肾脏病)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21091, categoryName=“福星”CKD-MBD学院, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4499, appHits=157, showAppHits=0, pcHits=606, showPcHits=4341, likes=0, shares=19, comments=3, approvalStatus=1, publishedTime=Sat Feb 12 15:14:00 CST 2022, publishedTimeString=2021-09-10, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Feb 12 00:18:14 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 17:24:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020年版中成药治疗慢性肾脏病3-5期(非透析)临床应用指南解读.pdf)])
2020年版中成药治疗慢性肾脏病3-5期(非透析)临床应用指南解读.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1196632, encodeId=79ff1196632f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0beb6511964, createdName=ms7000002138822538, createdTime=Thu Feb 24 00:10:28 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196559, encodeId=b5851196559ef, content=慢慢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/ca5757c5536d4ac281088cc3900b9c88/3cba1827c58b4f228391e0f93eda0e0b.jpg, createdBy=edd35267159, createdName=歆歆171107, createdTime=Wed Feb 23 21:23:32 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195927, encodeId=c15e119592eda, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0beb6511964, createdName=ms7000002138822538, createdTime=Tue Feb 22 01:02:50 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-24 ms7000002138822538

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196632, encodeId=79ff1196632f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0beb6511964, createdName=ms7000002138822538, createdTime=Thu Feb 24 00:10:28 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196559, encodeId=b5851196559ef, content=慢慢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/ca5757c5536d4ac281088cc3900b9c88/3cba1827c58b4f228391e0f93eda0e0b.jpg, createdBy=edd35267159, createdName=歆歆171107, createdTime=Wed Feb 23 21:23:32 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195927, encodeId=c15e119592eda, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0beb6511964, createdName=ms7000002138822538, createdTime=Tue Feb 22 01:02:50 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-23 歆歆171107

    慢慢学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1196632, encodeId=79ff1196632f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0beb6511964, createdName=ms7000002138822538, createdTime=Thu Feb 24 00:10:28 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196559, encodeId=b5851196559ef, content=慢慢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/ca5757c5536d4ac281088cc3900b9c88/3cba1827c58b4f228391e0f93eda0e0b.jpg, createdBy=edd35267159, createdName=歆歆171107, createdTime=Wed Feb 23 21:23:32 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195927, encodeId=c15e119592eda, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0beb6511964, createdName=ms7000002138822538, createdTime=Tue Feb 22 01:02:50 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-22 ms7000002138822538

    学习了

    0

相关指南

肾病患者静脉注射钆基对比剂——美国放射学会和国家肾脏基金会共识解读

北京大学第一医院医学影像科 · 2021-11-20

2021 NICE指南：慢性肾脏病的评估和管理（NG203）

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-08-25

慢性肾脏病继发甲状旁腺功能亢进外科临床实践中国专家共识（2021版）

中国医师协会外科医师分会 甲状腺外科医师委员会 · 2021-08-01

2021 G-CAN 共识声明：慢性肾脏病痛风的管理

痛风、高尿酸血症和晶体相关疾病网络（Gout, Hyperuricemia and Crystal-Associated Disease Network, G-CAN） · 2021-07-30

2021 ERA-EDTA/ERKNet实践建议：基因检测在慢性肾脏病诊断中的应用

欧洲肾脏学会-欧洲透析和移植学会(ERA-EDTA,European Renal Association&ndash;European Dialysis and Transplant Association) · 2021-07-15

2021 KDIGO临床实践指南：慢性肾脏病患者的血压管理

改善全球肾脏病预后组织(KDIGO,Kidney Disease: Improving Global Outcomes) · 2021-02-23